PMID- 30004669 OWN - NLM STAT- MEDLINE DCOM- 20190930 LR - 20191228 IS - 1936-086X (Electronic) IS - 1936-0851 (Print) IS - 1936-0851 (Linking) VI - 12 IP - 8 DP - 2018 Aug 28 TI - Multifarious Biologic Loaded Liposomes that Stimulate the Mammalian Target of Rapamycin Signaling Pathway Show Retina Neuroprotection after Retina Damage. PG - 7497-7508 LID - 10.1021/acsnano.8b00596 [doi] AB - A common event in optic neuropathies is the loss of axons and death of retinal ganglion cells (RGCs) resulting in irreversible blindness. Mammalian target of rapamycin (mTOR) signaling pathway agonists have been shown to foster axon regeneration and RGC survival in animal models of optic nerve damage. However, many challenges remain in developing therapies that exploit cell growth and tissue remodeling including (i) activating/inhibiting cell pathways synergistically, (ii) avoiding tumorigenesis, and (iii) ensuring appropriate physiological tissue function. These challenges are further exacerbated by the need to overcome ocular physiological barriers and clearance mechanisms. Here we present liposomes loaded with multiple mTOR pathway stimulating biologics designed to enhance neuroprotection after retina damage. Liposomes were loaded with ciliary neurotrophic factor, insulin-like growth factor 1, a lipopeptide N-fragment osteopontin mimic, and lipopeptide phosphatase tension homologue inhibitors for either the ATP domain or the c-terminal tail. In a mouse model of N-methyl-d-aspartic acid induced RGC death, a single intravitreal administration of liposomes reduced both RGC death and loss of retina electrophysiological function. Furthermore, combining liposomes with transplantation of induced pluripotent stem cell derived RGCs led to an improved electrophysiological outcome in mice. The results presented here show that liposomes carrying multiple signaling pathway modulators can facilitate neuroprotection and transplant electrophysiological outcome. FAU - Eriksen, Anne Z AU - Eriksen AZ AD - DTU Nanotech, Department of Micro- and Nanotechnology , Technical University of Denmark , 2800 Kongens Lyngby , Denmark. FAU - Eliasen, Rasmus AU - Eliasen R AD - DTU Nanotech, Department of Micro- and Nanotechnology , Technical University of Denmark , 2800 Kongens Lyngby , Denmark. FAU - Oswald, Julia AU - Oswald J AD - Schepens Eye Research Institute, Massachusetts Eye and Ear , 20 Staniford Street , Boston , Massachusetts 02114 , United States. FAU - Kempen, Paul J AU - Kempen PJ AD - DTU Nanotech, Department of Micro- and Nanotechnology , Technical University of Denmark , 2800 Kongens Lyngby , Denmark. FAU - Melander, Fredrik AU - Melander F AD - DTU Nanotech, Department of Micro- and Nanotechnology , Technical University of Denmark , 2800 Kongens Lyngby , Denmark. FAU - Andresen, Thomas L AU - Andresen TL AD - DTU Nanotech, Department of Micro- and Nanotechnology , Technical University of Denmark , 2800 Kongens Lyngby , Denmark. FAU - Young, Michael AU - Young M AD - Schepens Eye Research Institute, Massachusetts Eye and Ear , 20 Staniford Street , Boston , Massachusetts 02114 , United States. FAU - Baranov, Petr AU - Baranov P AUID- ORCID: 0000-0002-5526-7058 AD - Schepens Eye Research Institute, Massachusetts Eye and Ear , 20 Staniford Street , Boston , Massachusetts 02114 , United States. FAU - Urquhart, Andrew J AU - Urquhart AJ AUID- ORCID: 0000-0002-5322-0002 AD - DTU Nanotech, Department of Micro- and Nanotechnology , Technical University of Denmark , 2800 Kongens Lyngby , Denmark. LA - eng PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20180718 PL - United States TA - ACS Nano JT - ACS nano JID - 101313589 RN - 0 (Liposomes) RN - 0 (Neuroprotective Agents) RN - W36ZG6FT64 (Sirolimus) SB - IM MH - Animals MH - Liposomes MH - Mice MH - Mice, Inbred C57BL MH - Neuroprotective Agents/*pharmacology MH - Particle Size MH - Retinal Ganglion Cells/*drug effects/metabolism/pathology MH - Signal Transduction/*drug effects MH - Sirolimus/*pharmacology MH - Surface Properties PMC - PMC6117751 OTO - NOTNLM OT - ganglion OT - liposomes OT - neuropathy OT - neuroprotection OT - retina OT - transplant COIS- The authors declare no competing financial interest. EDAT- 2018/07/14 06:00 MHDA- 2019/10/01 06:00 PMCR- 2018/08/31 CRDT- 2018/07/14 06:00 PHST- 2018/07/14 06:00 [pubmed] PHST- 2019/10/01 06:00 [medline] PHST- 2018/07/14 06:00 [entrez] PHST- 2018/08/31 00:00 [pmc-release] AID - 10.1021/acsnano.8b00596 [doi] PST - ppublish SO - ACS Nano. 2018 Aug 28;12(8):7497-7508. doi: 10.1021/acsnano.8b00596. Epub 2018 Jul 18.